Monash IVF Group has attracted 31 new doctors to join our teams in Victoria, New South Wales, Queensland, Western Australia, South Australia, Northern Territory and South-East Asia through acquisition, recruitment and our own internal training programs.
We now have a total of 146 clinicians working in IVF and Women’s Ultrasound. The highlights for FY22 included Monash IVF establishing its presence in Western Australia with the acquisition of PIVET Medical Centre and its team of 9 clinicians and the opening of a new clinic in Singapore built around 4 experienced IVF Doctors.
Our Doctor engagement continues to show positive progress in aligning to our doctor value proposition. In FY22, we adjusted our engagement metrics to measure NPS (net promoter score) engagement through our clinicians recommendation as a place to practice and as a place to provide quality service to patients.
In 2022, we recorded the highest NPS score, and a score well above industry benchmark in recommending Monash IVF Group to patients in providing quality service. We also retained a higher than industry benchmark NPS for recommending Monash IVF as a place to practice.
Our clinicians, in collaboration with our scientists, have led the way in continuing to improve our success rates year-onyear. This has been achieved through meticulous continuous improvement and implementation of best clinical practice in all of our clinics in Australia and South-East Asia. We continue our investment program of installing Time-Lapse incubators across our clinics to improve embryo culture systems, and PIEZO ICSI technology to improve fertilisation rates in our science laboratories.
A new research governance framework was implemented which includes a primary committee to oversee the introduction of new clinical practices and research at Monash IVF. This committee had its inaugural meeting in FY22 and is independently chaired by Professor Jock Findlay of the Hudson Institute of Medical Research. Through this, the Monash Research and Education Fund (MREF) distributed more than $400K of research grants to projects led by our clinicians, scientists and nurses.
Our clinicians hold senior academic roles at numerous Universities and Institutes, as well as being active investigators on Medical Research Future Fund (MRFF) and National Health and Medical Research Council (NHMRC) grants, and clinical trial cohort studies. Collectively we remain at the cutting edge of reproductive healthcare.
A special mention also to our clinical and ultrasound teams who led our people to remain open throughout the pandemic to provide critical pregnancy scan services whilst public hospital services were unable to due to COVID response priorities.
Monash IVF Group doctor partnerships are a cornerstone pillar of our strategic vision. We have a very clear strategy to continue to build upon our already elite clinical team by attracting the very best clinicians, both through acquisition and our own CREI training programs. Fundamental to achieving this will be continuing to invest in the very best science and clinical technology to ensure our patients have the best chance of success.
1. July 2021-August 2022